|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.29 CAD | -9.38% |
|
-9.38% | -14.71% |
| 21/06 | Ocumetics Technology Corp. announced that it has received CAD 3.76 million in funding | CI |
| 30/05 | Ocumetics Technology Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Ocumetics Technology Corp. ("Ocumetics") announced a partnership with Bioana SAPI de CV ("Bioana"), a female-led medical device development company based in Monterey, Mexico. Bioana has extensive experience in feasibility studies, concept development, design for manufacturing, small batch prototype production, verification and validation testing, FDA clearance and approval, and Ocumetics Technology Corp.
Partners with Female-Led Bioanadevelopment of intellectual property and branding.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.71% | 25.48M | |
| +6.49% | 7.7B | |
| -6.52% | 4.54B | |
| +3.34% | 3.21B | |
| +13.62% | 2.26B | |
| +8.43% | 1.04B | |
| +8.41% | 970M | |
| -43.67% | 872M | |
| -34.38% | 633M | |
| -61.84% | 614M |
OCUMETICS TECHNOLOGY CORP. 
